| |DECEMBER 202519With its blend of expertise, technology, global reach, & forward momentum, G&L scientific is helping define the future of regulatory excellenceand key growth markets. Through its APAC hubs, G&L supports bidirectional regulatory expansion, enabling Asian innovators to enter the US and Europe, and helping Western organizations scale into high-volume Asian markets. This combination of globally aligned strategy and locally optimized execution enables faster submissions, smoother approvals, and sustained compliance, with first-time-right delivery as a core operating principle. Global expertise, local execution, and digital innovation come together to create a seamless partnership.Staying Ahead through Knowledge &TrainingRegulatory intelligence is central to G&L's delivery model. While the industry shifts toward AI-based monitoring, G&L maintains that expert interpretation remains essential where nuance determines success. A sophisticated internal intelligence platform aggregates updates from 100+ Health Authorities, reinforced by Lessons Learned workshops and region-specific expert forums. This ensures that consultants remain aligned with the evolving regulatory intent, not just the evolving regulatory text. Even in an age of automation, G&L places the human element at the centre of accuracy and insight.Digital Enablement meets DomainExpertiseTechnology acts as a powerful accelerator within G&L's delivery model. Digital solutions are designed to solve real client challenges, not add complexity. G&L brings a practical, problem-solving approach to modernizing processes, improving efficiency, strengthening visibility, and enhancing regulatory control.The Road Ahead: A Low-risk GCC Alternative for ClientsG&L's forward strategy spans three key dimensions:· Deepening scientific specialization - Focused investments in emerging areas including ATMPs and Cell & Gene Therapies.· Being a scalable GCC-alternative - By enhancing its Functional Service Outsourcing (FSO) model, G&L can operate as a ready-built, low-risk GCC, especially valuable for small and mid-sized pharma seeking operational scalability without the complexity, capital, and oversight required to establish a captive capability centre.· Advancing predictive regulatory intelligence - Strengthening proactive strategy to accelerate timelines, reduce friction, and protect asset value.A Partner for the Future of Global PharmaAs the pharmaceutical industry advances, the expectations of regulatory partnership are evolving with it. With its blend of expertise, technology, global reach, and forward momentum, G&L Scientific is helping define the future of regulatory excellence. Its story continues to unfold, but one truth is clear: G&L Scientific is not simply keeping pace with change. It is helping create it. POPHARMA REGULATORY CONSULTING STARTUPS - 2025TOP 10
< Page 9 | Page 11 >